# Cellectis S.A.: Form 20-F for the period ended Dec 31, 2023

- Company: [Cellectis S.A.](/companies/clls.md) (CIK 1627281)
- Form: 20-F
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 17:01 ET
- Period: 2023-12-31
- Accession: 0000950170-24-050016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1627281/000095017024050016/clls-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1627281/000095017024050016/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | $755.0k | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | $737.0k | ifrs-full:CostOfSales |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | −$97.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $371.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | −$101.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | −$1.77 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | −$1.77 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | −$24.7m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | $1.1m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2023-12-31 | $136.7m | ifrs-full:CashAndCashEquivalents |
| Total assets | at 2023-12-31 | $334.3m | ifrs-full:Assets |
| Current liabilities | at 2023-12-31 | $155.1m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2023-12-31 | $84.7m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2023-12-31 | 71,751,201 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1627281/000095017024050016/clls-20231231.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-050016. Last ingested by Listed: Oct 28, 2026, 06:05 ET. No prices; not investment advice.